Clinical trial
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
NCT00385684 · VA Office of Research and Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00385684 |
|---|---|
| Title | Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT) |
| Official title | Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT) |
| Acronym | LDOT |
| Lead sponsor | VA Office of Research and Development, U.S. Fed |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alzheimer Disease, Dementia, Vascular, Pain |
| Intervention type | Drug |
| Interventions | hydrocodone/APAP w placebo PRN, hydrocodone/APAP, placebo with hydrocodone/APAP PRN |
| Enrollment | 11 |
| Start date | Oct 1, 2007 |
| Primary completion | Dec 1, 2011 |
| Completion | Jun 1, 2014 |
| First posted | Oct 11, 2006 |
| Last update posted | Nov 20, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: